praziquantel has been researched along with Liver Dysfunction in 23 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "In view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma mansoni after Praziquantel (PZQ) treatment." | 7.96 | Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. ( Alves, ÉAR; Bicalho, KA; Birbrair, A; Bozzi, A; Chaves, AT; Corrêa-Oliveira, R; de Goes, AM; Eller, DE; Ferraz, LCN; Gomes, TR; Miranda, VHS; Pascoal Xavier, MA; Silva, CEC, 2020) |
| "Inflammation of the hepatobiliary system in chronic opisthorchiasis is associated with an elevated level of urinary 8-oxo-7,8 dihydro-2'deoxyguanosine (8-oxodG) during active as well as past exposure to Opisthorchis viverrini infection." | 7.91 | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. ( Bethony, JM; Chamadol, N; Eamudomkarn, C; Jumnainsong, A; Khuntikeo, N; Loilome, W; Pinlaor, S; Sithithaworn, J; Sithithaworn, P; Techasen, A; Thanan, R; Wangboon, C; Worasith, C; Yongvanit, P, 2019) |
| "In praziquantel-treated mice (500 mg/kg for 2 days orally), the reduction in the percent resistance (45." | 5.28 | Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, A; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1989) |
| "Mice treated with praziquantel showed a prompt decrease in S." | 5.27 | Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. ( Dunn, MA; Girgis, NI; Ishak, EA; Khayyal, MT; Mansour, MM; Morcos, SH; Saleh, S, 1985) |
| " The effect of prolonged administration of bevacizumab with praziquantel was also assessed through parasitic load, protective index, granuloma and fibrous tissue evaluation." | 3.96 | Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon. ( El-Anwar, N; Hasby Saad, MA, 2020) |
| "In view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma mansoni after Praziquantel (PZQ) treatment." | 3.96 | Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. ( Alves, ÉAR; Bicalho, KA; Birbrair, A; Bozzi, A; Chaves, AT; Corrêa-Oliveira, R; de Goes, AM; Eller, DE; Ferraz, LCN; Gomes, TR; Miranda, VHS; Pascoal Xavier, MA; Silva, CEC, 2020) |
| "Inflammation of the hepatobiliary system in chronic opisthorchiasis is associated with an elevated level of urinary 8-oxo-7,8 dihydro-2'deoxyguanosine (8-oxodG) during active as well as past exposure to Opisthorchis viverrini infection." | 3.91 | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. ( Bethony, JM; Chamadol, N; Eamudomkarn, C; Jumnainsong, A; Khuntikeo, N; Loilome, W; Pinlaor, S; Sithithaworn, J; Sithithaworn, P; Techasen, A; Thanan, R; Wangboon, C; Worasith, C; Yongvanit, P, 2019) |
| "Treatment with praziquantel reduces the prevalence and intensity of Schistosoma mansoni infection." | 3.70 | Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. ( Doehring, E; Frenzel, K; Grigull, L; Loroni-Lakwo, T; Ndugwa, CM; Odongo-Aginya, E; Schweigmann, U; Spannbrucker, N; Vester, U, 1999) |
| "Non steroidal anti-inflammatory drugs (NSAIDs) (tiaprofenic acid and piroxicam have been used alone and as adjuvants to praziquantel in treating hepatic granuloma in Schistosoma mansoni infected mice." | 3.69 | Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice. ( Hegazy, IH; Moussa, SM; Nassar, SH, 1997) |
| " The efficacy of BAPN, alone or in association with the anti-schistosomal drug, praziquantel (PZQ), was primarily assessed by measuring the reduction in liver and intestinal egg loads in murine schistosomiasis mansoni." | 3.68 | Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report. ( Giboda, M; Julis, I; Vítovec, J; Zenka, J, 1992) |
| "Peripheral blood T cell phenotypes, CD3-induced mitogenesis and soluble IL 2 receptor and CD8 in sera were studied in intestinal and hepatosplenic Schistosomiasis mansoni before and three to six months after therapy with praziquantel." | 3.67 | T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy. ( Bienzle, U; Correia Dacal, AR; Feldmeier, H; Harms, G; Jansen-Rosseck, R; Vergetti de Siqueira, JG; Zwingenberger, K, 1989) |
| " Unfortunately, it exhibits low oral bioavailability which can compromise its efficacy." | 1.51 | Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation. ( Abd Elazeem, MA; Aboul Asaad, IA; El Maghraby, GM; El-Kowrany, SI; El-Nouby, KA; Zoghroban, HS, 2019) |
| "Tests for a haemochromatosis gene and its type showed a homozygotic C282Y variant." | 1.30 | [Flu-like infection and liver disease after a stay in the tropics]. ( Gehrke, S; Nothdurft, HD; Schneider, M; Stremmel, W, 1999) |
| "In praziquantel-treated mice, the reduction in the per cent resistance was accompanied by a diminution in the size of hepatic granulomata and its in vivo correlate the delayed foot pad swelling." | 1.28 | Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, AA; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1990) |
| "In praziquantel-treated mice (500 mg/kg for 2 days orally), the reduction in the percent resistance (45." | 1.28 | Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, A; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1989) |
| "Mice treated with praziquantel showed a prompt decrease in S." | 1.27 | Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. ( Dunn, MA; Girgis, NI; Ishak, EA; Khayyal, MT; Mansour, MM; Morcos, SH; Saleh, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Atwa, MTM | 1 |
| Abd-Elrazek, AM | 1 |
| Salem, NIS | 1 |
| Hasby Saad, MA | 1 |
| El-Anwar, N | 1 |
| Miranda, VHS | 1 |
| Gomes, TR | 1 |
| Eller, DE | 1 |
| Ferraz, LCN | 1 |
| Chaves, AT | 1 |
| Bicalho, KA | 1 |
| Silva, CEC | 1 |
| Birbrair, A | 1 |
| Pascoal Xavier, MA | 1 |
| de Goes, AM | 1 |
| Corrêa-Oliveira, R | 1 |
| Alves, ÉAR | 1 |
| Bozzi, A | 1 |
| Abd El-Aal, NF | 1 |
| Hamza, RS | 1 |
| Magdy, M | 1 |
| Wangboon, C | 1 |
| Worasith, C | 1 |
| Thanan, R | 1 |
| Eamudomkarn, C | 1 |
| Techasen, A | 1 |
| Sithithaworn, J | 1 |
| Loilome, W | 1 |
| Chamadol, N | 1 |
| Pinlaor, S | 1 |
| Jumnainsong, A | 1 |
| Yongvanit, P | 1 |
| Khuntikeo, N | 1 |
| Bethony, JM | 1 |
| Sithithaworn, P | 1 |
| Zoghroban, HS | 1 |
| El-Kowrany, SI | 1 |
| Aboul Asaad, IA | 1 |
| El Maghraby, GM | 1 |
| El-Nouby, KA | 1 |
| Abd Elazeem, MA | 1 |
| Bustinduy, AL | 1 |
| Luzinda, K | 1 |
| Mpoya, S | 1 |
| Gothard, P | 1 |
| Stone, N | 1 |
| Wright, S | 1 |
| Stothard, JR | 1 |
| Argirovic, N | 1 |
| Caselitz, M | 1 |
| Mohren, W | 1 |
| Cruz Cordero, F | 1 |
| Huber, J | 1 |
| Wagner, S | 1 |
| Zhu, ZJ | 1 |
| Shen, ZY | 1 |
| Gao, W | 1 |
| Zheng, H | 1 |
| Deng, YL | 1 |
| Pan, C | 1 |
| Sun, LY | 1 |
| Zeng, ZG | 1 |
| Sun, JS | 1 |
| Traore, HA | 1 |
| Maiga, MY | 1 |
| Sogodogo, S | 1 |
| Dembele, M | 1 |
| Sidibe, TA | 1 |
| Diallo, D | 1 |
| Diallo, AN | 1 |
| Guindo, A | 1 |
| Pichard, E | 1 |
| Doumbo, O | 1 |
| El-Banhawey, MA | 1 |
| Ashry, MA | 1 |
| El-Ansary, AK | 1 |
| Aly, SA | 1 |
| Mehlhorn, H | 1 |
| Frenkel, JK | 1 |
| Andrews, P | 1 |
| Thomas, H | 1 |
| Johansen, MV | 1 |
| Monrad, J | 1 |
| Christensen, NO | 1 |
| Lindberg, R | 1 |
| Botros, SS | 3 |
| Doughty, BL | 1 |
| Shaker, ZA | 3 |
| Akl, MM | 1 |
| Sharmy, R | 1 |
| Diab, TM | 1 |
| Hassanein, HI | 1 |
| Hegazy, IH | 1 |
| Nassar, SH | 1 |
| Moussa, SM | 1 |
| Frenzel, K | 1 |
| Grigull, L | 1 |
| Odongo-Aginya, E | 1 |
| Ndugwa, CM | 1 |
| Loroni-Lakwo, T | 1 |
| Schweigmann, U | 1 |
| Vester, U | 1 |
| Spannbrucker, N | 1 |
| Doehring, E | 1 |
| Schneider, M | 1 |
| Gehrke, S | 1 |
| Nothdurft, HD | 1 |
| Stremmel, W | 1 |
| Giboda, M | 1 |
| Zenka, J | 1 |
| Julis, I | 1 |
| Vítovec, J | 1 |
| Hassan, SI | 2 |
| el-Nahal, HM | 2 |
| Azab, ME | 2 |
| el-Garem, AA | 1 |
| Zwingenberger, K | 1 |
| Harms, G | 1 |
| Vergetti de Siqueira, JG | 1 |
| Correia Dacal, AR | 1 |
| Jansen-Rosseck, R | 1 |
| Bienzle, U | 1 |
| Feldmeier, H | 1 |
| el-Garem, A | 1 |
| Thammapalerd, N | 1 |
| Tharavanij, S | 1 |
| Nacapunchai, D | 1 |
| Bunnag, D | 1 |
| Radomyos, P | 1 |
| Prasertsiriroj, V | 1 |
| Morcos, SH | 1 |
| Khayyal, MT | 1 |
| Mansour, MM | 1 |
| Saleh, S | 1 |
| Ishak, EA | 1 |
| Girgis, NI | 1 |
| Dunn, MA | 1 |
23 other studies available for praziquantel and Liver Dysfunction
| Article | Year |
|---|---|
Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
Topics: Animals; Anthelmintics; Granuloma; Liver; Liver Diseases; Mice; Plant Extracts; Praziquantel; Schist | 2022 |
Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Chronic Disease; Granuloma; Liver Diseases; Male; Mic | 2020 |
Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment.
Topics: Adipose Tissue; Animals; Cell- and Tissue-Based Therapy; Cytokines; Disease Models, Animal; Granulom | 2020 |
Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis.
Topics: Animals; Artemether; Artemisinins; Female; Granuloma; Liver Diseases; Mice; Praziquantel; Schistosom | 2017 |
Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anthelmintics; Biliary Tract Diseases; Biomarkers; Deoxyguanos | 2019 |
Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Topics: Animals; Biological Availability; Female; Humans; Intestines; Liposomes; Liver Diseases; Male; Mice; | 2019 |
Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?
Topics: Animals; Anthelmintics; Child; Endomyocardial Fibrosis; Feces; Humans; Liver Diseases; Male; Praziqu | 2014 |
[Peranal bleeding and elevated liver function tests in a 33‑year-old refugee from Nigeria].
Topics: Adult; Anthelmintics; Anus Diseases; Diagnosis, Differential; Hemorrhage; Humans; Liver Diseases; Li | 2016 |
Feasibility of using a liver infected with Clonorchis sinensis for liver transplantation: fourteen cases.
Topics: Adult; Animals; Anthelmintics; Clonorchiasis; Clonorchis sinensis; Feasibility Studies; Female; Foll | 2010 |
[Importance of hepatic bilharziasis in liver pathologies in the internal medicine department of the National Hospital of Point "G", Bamako-Mali].
Topics: Adolescent; Adult; Aged; Anthelmintics; Biopsy; Child; Female; Granuloma; Hepatomegaly; Hospital Dep | 1996 |
Effect of Curcuma longa or parziquantel on Schistosoma mansoni infected mice liver--histological and histochemical study.
Topics: Alkaline Phosphatase; Animals; Body Weight; Curcuma; Liver Diseases; Male; Mice; Organ Size; Phytoth | 2007 |
Light and electron microscopic studies on Schistosoma mansoni Granulomas of mouse livers following treatment with praziquantel.
Topics: Animals; Female; Granuloma; Isoquinolines; Liver; Liver Diseases; Mice; Ovum; Praziquantel; Schistos | 1982 |
Experimental Schistosoma bovis infection in goats: pathological consequences of praziquantel treatment.
Topics: Animals; Antiplatyhelmintic Agents; Female; Goats; Granuloma; Intestines; Liver; Liver Diseases; Lym | 1996 |
Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Female; Granuloma; Immune Tolerance; Immunoglobul | 1996 |
Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Dinoprostone; Drug Therapy, Combinatio | 1997 |
Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Child; Child, Preschool; Feces; Female; Humans; Inter | 1999 |
[Flu-like infection and liver disease after a stay in the tropics].
Topics: Adult; Africa, Southern; Anthelmintics; Biopsy; Clinical Enzyme Tests; Diagnosis, Differential; Fece | 1999 |
Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report.
Topics: Aminopropionitrile; Animals; Collagen; Drug Therapy, Combination; Female; Granuloma; Intestinal Dise | 1992 |
Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosomiasis mansoni.
Topics: Animals; Antibody Formation; Granuloma; Liver Diseases; Mice; Praziquantel; Schistosomiasis mansoni; | 1990 |
T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
Topics: Adolescent; Adult; Aged; Antigens, CD; Child; Female; Humans; Liver Diseases; Lymphocyte Activation; | 1989 |
Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Animals; Drug Therapy, Combination; Granuloma; Hypersensitivity, Delayed; Hy | 1989 |
Detection of antibodies against Opisthorchis viverrini in patients before and after treatment with praziquantel.
Topics: Animals; Antibodies, Helminth; Concanavalin A; Enzyme-Linked Immunosorbent Assay; Hemagglutination T | 1988 |
Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.
Topics: Animals; Collagen; Granuloma; Hydroxyproline; Isoquinolines; Liver; Liver Diseases; Male; Mice; Orga | 1985 |